APRINOIA Therapeutics via Ross Acquisition II (ROSS) deck
APRINOIA offers patients with neurodegenerative diseases the hope of protecting their brain health and preserving their dignity through next-generation diagnostic tools and targeted therapeutics.
%20deck){kind=link}